Response to brentuximab vedotin plus CHP according to CD30 expression in the ECHELON-2 trial Illidge, T., Horwitz, S., Iyer, S., Bartlett, N., Kim, W. S., Belada, D., Feldman, T., Illes, A., Jacobsen, E., Huettmann, A., Zinzani, P. L., O'Connor, O., Mckay, P., Trepicchio, W., Miao, H., Fenton, K., Onsum, M., Manley, T., Advani, R. WILEY. 2020: 111–12

View details for Web of Science ID 000528597400151